Article
[Identification of a novel CYP2C9 gene mutation (1400T>C) and assessment of its enzymatic activity in vitro].
Zhonghua yi xue za zhi - 26 Nov 2013
Dai Da-peng, Li Chuan-bao, Wang Shuang-hu, Geng Pei-wu, Hu Guo-xin, Cai Jian-ping
Abstract excerpt
OBJECTIVE: To perform a pharmacogenetic study of a patient with warfarin hypersensitivity and determine the biological function of a novel CYP2C9 mutation. METHODS: Genomic DNAs were extracted from the warfarin hypersensitive patient and used for genetic screening of CYP2C9, VKORC1 and CYP4F2 by direct sequencing. Acquired sequences were aligned and blasted with public nucleotide database to clarify whether site...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
